A History of Outperforming Analyst Forecasts and Beating the Odds: Precigen Inc (PGEN)

With 0.52 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.15 million shares. The 52-week range on PGEN shows that it touched its highest point at $1.88 and its lowest point at $0.84 during that stretch. It currently has a 1-year price target of $9.00. Beta for the stock currently stands at 1.73.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PGEN was up-trending over the past week, with a rise of 2.51%, but this was down by -7.14% over a month. Three-month performance surged to 1.42% while six-month performance rose 0.70%. The stock gained 40.20% in the past year, while it has gained 6.72% so far this year. A look at the trailing 12-month EPS for PGEN yields -0.39 with Next year EPS estimates of -0.27. For the next quarter, that number is -0.09. This implies an EPS growth rate of 13.85% for this year and 20.83% for next year. EPS is expected to grow by 2.40% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 36.94%.

Float and Shares Shorts:

At present, 248.92 million PGEN shares are outstanding with a float of 123.71 million shares on hand for trading. On Mar 15, 2024, short shares totaled 16.91 million, which was 6.79% higher than short shares on Feb 15, 2024. In addition to AGEN as the firm’s Agenus Inc., CGEN serves as its Compugen Ltd.

Institutional Ownership:

Through their ownership of 64.22% of PGEN’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PGEN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, PGEN has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and PGEN currently yields $0.00. In the past year, PGEN’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, PGEN has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.